ARTW Arts Way Manufacturing Co Inc

ART’S-WAY MANUFACTURING CO., INC.

5556 Highway 9

Armstrong, Iowa, 50514-0288

Ph: (712) 208-8467

 

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD ON WEDNESDAY, APRIL 23, 2025

 

To our Stockholders:

 

The 2025 Annual Meeting of the Stockholders (the “2025 Annual Meeting”) of Art’s-Way Manufacturing Co., Inc. (the “Company”) will be held on Wednesday, April 23, 2025, at the offices of the Company located at 5556 Highway 9, Armstrong, Iowa, 50514-0288. Registration for the 2025 Annual Meeting will begin at 9:30 a.m. Central Daylight Time (“CDT”). The 2025 Annual Meeting will commence at approximately 10:00 a.m. CDT. The Company is also offering its stockholders the ability to attend the 2025 Annual Meeting remotely, via teleconference. To attend the 2025 Annual Meeting via teleconference, please call 1-866-895-5510 and enter a passcode of 409589. The purposes of the 2025 Annual Meeting are to:

 

(1)

Consider and vote upon the election of five nominees to the Company’s Board of Directors, to serve until the next annual meeting of stockholders and until such time as their successors are elected and qualified, or until their earlier resignation or removal;

 

(2)

Consider and vote upon the ratification of the appointment of Eide Bailly LLP as the Company’s independent registered public accounting firm for the fiscal year ending November 30, 2025;

 

(3)

Consider and vote upon, on a non-binding, advisory basis, a proposal to approve the Company’s named executive officer compensation; and

 

(4)

Consider and recommend, on a non-binding, advisory basis, whether the vote on named executive officer compensation should occur every year, every two years, or every three years.

 

Any action may be taken on any one of the foregoing proposals at the 2025 Annual Meeting on the date specified above, or on any date or dates to which the 2025 Annual Meeting may be adjourned. The Board of Directors is not aware of any other business to come before the 2025 Annual Meeting. The foregoing proposals are described more fully in the enclosed proxy statement (the “Proxy Statement”). If you have any questions regarding the information contained in the Proxy Statement or submission of your proxy for the 2025 Annual Meeting or if you would like directions to the 2025 Annual Meeting, please call the Company at (712) 208-8467.

 

Only stockholders listed on the Company’s records at the close of business on Friday, March 7, 2025, the record date set by the Board of Directors for the 2025 Annual Meeting, are entitled to notice of the 2025 Annual Meeting and to vote at the 2025 Annual Meeting and any adjournments thereof. The stock transfer books of the Company will not be closed.

 

All stockholders are cordially invited to attend the 2025 Annual Meeting in person or via teleconference. In-person voting will not be available if you attend the 2025 Annual Meeting via teleconference. Therefore, to ensure the presence of a quorum, the Board of Directors requests all stockholders of record to promptly vote your shares by proxy, whether or not you plan to attend the 2025 Annual Meeting. The proxy is revocable and will not be used if a stockholder attends and votes at the 2025 Annual Meeting in person or otherwise provides notice of revocation. You may vote by proxy over the telephone or the Internet as instructed in the accompanying proxy statement. If you received a proxy card or voting instruction card by mail, you may submit your proxy card or voting instruction card by completing, signing, dating and mailing your proxy card or voting instruction card in the envelope provided.

 

By order of the Board of Directors,

 

/s/ Marc H. McConnell

Chairman, President and CEO

Armstrong, Iowa

March 14, 2025

 

 

IMPORTANT: THE PROMPT RETURN OF PROXIES WILL SAVE THE COMPANY THE EXPENSE OF FURTHER REQUESTS FOR PROXIES IN ORDER TO ENSURE A QUORUM.

 

Proxy Statement

2025 Annual Meeting of Stockholders

Wednesday, April 23, 2025

10:00 a.m. CDT

 

This proxy statement (the “Proxy Statement”) is furnished in connection with the solicitation of proxies by the Board of Directors of Art’s-Way Manufacturing Co., Inc., a Delaware corporation (the “Company,” “we,” “us,” or “our”), for use at the 2025 Annual Meeting of Stockholders of the Company to be held on Wednesday, April 23, 2025 (the “2025 Annual Meeting”), and at any adjournment thereof. The 2025 Annual Meeting will be held at the offices of the Company located at 5556 Highway 9, Armstrong, Iowa, 50514-0288. Registration for the 2025 Annual Meeting will begin at approximately 9:30 a.m. Central Daylight Time (“CDT”). The 2025 Annual Meeting will commence at approximately 10:00 a.m. CDT. This solicitation is being made by mail; however, the Company may also use its officers, directors, and employees (without providing them with additional compensation) to solicit proxies from stockholders in person, by telephone, electronically, or by letter. Distribution of this Proxy Statement and the proxy card via U.S. Mail is scheduled to begin on or about March 14, 2025.

 

Important Notice Regarding the Availability of Proxy Materials

for the Annual Meeting of Stockholders to be Held on April 23, 2025:

The Notice, Proxy Statement, Form of Proxy Card, and Annual Report on Form 10-K are available at

http://www.artsway-mfg.com/financials-and-filings/

 

QUESTIONS AND ANSWERS ABOUT THE 2025 ANNUAL MEETING AND VOTING

 

Q:	Why did I receive this Proxy Statement?
A:	We are soliciting your proxy for the 2025 Annual Meeting because you owned of record one or more shares of common stock of the Company at the close of business on Friday, March 7, 2025, the record date for the 2025 Annual Meeting, and are therefore entitled to vote at the 2025 Annual Meeting.

 

Q:	What is a proxy?
A:	A proxy is your legal designation of another person or persons (the “proxy” or “proxies,” respectively) to vote on your behalf. By completing and returning the enclosed proxy card or by voting via the Internet or telephone, you are giving Marc H. McConnell and Matthew Westendorf, the proxies, the authority to vote your shares of common stock at the 2025 Annual Meeting in the manner you indicate. If you sign and return your proxy card, but do not give direction with respect to any nominee or other proposal, the proxies will vote your shares as recommended by the Board of Directors. The proxies are authorized to vote in their discretion if other matters are properly submitted at the 2025 Annual Meeting or any adjournments thereof.

 

Q:	When and where is the 2025 Annual Meeting?
A:	The 2025 Annual Meeting will be held on Wednesday, April 23, 2025 at the offices of the Company located at 5556 Highway 9, Armstrong, Iowa, 50514-0288. Registration for the meeting will begin at approximately 9:30 a.m. CDT. The 2025 Annual Meeting will commence at approximately 10:00 a.m. CDT. The Company is also offering its stockholders the ability to attend the 2025 Annual Meeting remotely, via teleconference. To attend the 2025 Annual Meeting via teleconference, please call 1-866-895-5510 and enter a passcode of 409589. In-person voting will not be available if you attend the 2025 Annual Meeting via teleconference.

 

Q:	What am I voting on?
A:	You are voting on the following matters:

 

•

Proposal 1 — The election of the five director nominees named in this Proxy Statement;

 

 

	•	Proposal 2 — The ratification of the appointment of Eide Bailly LLP as the Company’s independent registered public accounting firm for the fiscal year ending November 30, 2025 (“fiscal year 2025”);
	•	Proposal 3 — The approval, on a non-binding, advisory basis, of the Company’s named executive officer compensation.
	•	Proposal 4 — The recommendation, on a non-binding, advisory basis, whether the vote on named executive officer compensation should occur every year, every two years, or every three years.

 

Q:	What does the Board recommend?
A:	The Board recommends a vote:

 

	•	FOR — the election of the five director nominees named in this Proxy Statement;
	•	FOR — the ratification of the appointment of Eide Bailly LLP as the Company’s independent registered public accounting firm for fiscal year 2025;
	•	FOR — the approval, on a non-binding, advisory basis, of the Company’s named executive officer compensation.
	•	ONE YEAR — as the recommendation, on a non-binding, advisory basis, of the frequency that the vote on named executive officer compensation should occur.

 

Q:	How many votes do I have?
A:	On any matter that may properly come before the 2025 Annual Meeting, each stockholder entitled to vote thereon will have one vote for each share of common stock owned of record by such stockholder as of the close of business on March 7, 2025.

 

Q:	How many shares of common stock may vote at the 2025 Annual Meeting?
A:	At the close of business on March 7, 2025, there were 5,086,584 shares of common stock outstanding. This means that there may be 5,086,584 votes on any matter presented at the 2025 Annual Meeting.

 

Q:	What vote is required to approve each of the Proposals?
A:	Proposal 1 — Election of Directors — With respect to the election of directors, the five nominees receiving the greatest number of votes cast relative to the votes cast for the other nominees will be elected, regardless of whether an individual nominee receives votes from a majority of the quorum of shares represented (in person or by proxy) at the 2025 Annual Meeting and entitled to vote on the proposal. Although directors are elected by plurality vote, the presence (in person or by proxy) of stockholders representing at least a majority of the issued and outstanding shares of common stock is required to constitute a quorum for the election of directors.   Proposal 2 — Independent Registered Public Accounting Firm — Provided a quorum of at least a majority of the issued and outstanding shares of common stock is present (in person or by proxy), the affirmative vote of the holders of a majority of the shares of common stock represented at the 2025 Annual Meeting (whether in person or by proxy) and entitled to vote on the proposal will result in the stockholders’ ratification of the appointment of Eide Bailly LLP as the Company’s independent registered public accounting firm for fiscal year 2025.   Proposal 3 — Approval, on a Non-Binding, Advisory Basis, of the Company’s Named Executive Officer Compensation — Provided a quorum of at least a majority of the issued and outstanding shares of common stock is present (in person or by proxy), the affirmative vote of the holders of a majority of the shares of common stock represented at the 2025 Annual Meeting (whether in person or by proxy) and entitled to vote on the proposal will result in the approval of the compensation of our named executive officers. However, this is an advisory vote, which means that the result of the vote is not binding on the Company, the Board of Directors or the Compensation Committee. To the extent there is any significant vote against the Company’s named executive officer compensation as disclosed in this Proxy Statement, the Compensation Committee will evaluate whether any actions are necessary to address the concerns of stockholders.   Proposal 4 — Recommendation, on a Non-Binding, Advisory Basis, of the Frequency of Votes on Named Executive Officer Compensation — Provided a quorum of at least a majority of the issued and outstanding shares of common stock is present (in person or by proxy), the alternative receiving the greatest number of votes cast relative to the votes cast for the other alternatives will be deemed the alternative recommended by the stockholders. However, this is an advisory vote, which means that the result of the vote is not binding on the Company, the Board of Directors or the Compensation Committee. The Board of Directors and the Compensation Committee will take into account the outcome of the vote when determining the frequency of future advisory votes on the Company’s named executive officer compensation.

 

 

Q:	Do stockholders have cumulative voting rights?
A:	Stockholders do not have cumulative voting rights with respect to the election of directors or any other matter, which means that stockholders will not be able to cast all of their votes for a single director nominee. The cumulative voting method would entitle a stockholder to multiply the number of shares owned of record by such stockholder by the number of director positions being voted upon and then cast a number of votes equal to such total for only one nominee. Instead, stockholders will only be able to cast one vote per share owned of record for each director nominee (up to five nominees) at the 2025 Annual Meeting. Accordingly, a holder of 100 shares will only be able to cast 100 votes for each of the five nominees (or any lesser number of nominees, as desired) and will not instead be able to cast 500 votes for a single nominee (or distribute votes in any other manner).

 

Q:	What constitutes a quorum?
A:	Transaction of business may occur at the 2025 Annual Meeting if a quorum is present. The presence in person or by proxy of stockholders holding at least a majority of the issued and outstanding shares of common stock is required to constitute a quorum. On March 7, 2025, the Company had 5,086,584 shares of common stock issued and outstanding and, therefore, the presence of 2,543,293 shares will constitute a quorum for the transaction of business at the 2025 Annual Meeting. If you submit a proxy or vote in person at the meeting, your shares will be counted in determining whether a quorum is present at the 2025 Annual Meeting. Broker non-votes and abstentions are also counted for the purpose of determining a quorum, as discussed below.

 

Q:	What is the effect of abstentions and withhold votes?
A:	You may either vote FOR or WITHHOLD authority to vote for each director nominee (Proposal 1). If you withhold authority to vote on any or all nominees, your vote will have no effect on the outcome of the election. You may vote FOR, AGAINST or ABSTAIN on the ratification of Eide Bailly LLP as the Company’s independent registered public accounting firm for fiscal year 2025 (Proposal 2), and the non-binding, advisory vote to approve named executive officer compensation (Proposal 3). If you abstain from voting on any of these proposals, your shares will be deemed present but will not be deemed to have voted in favor of the proposal. An abstention therefore has the same effect as a vote against the proposal. You may vote for ONE YEAR, TWO YEARS, or THREE YEARS or you may ABSTAIN on the non-binding, advisory recommendation on the frequency of votes on named executive officer compensation (Proposal 4). If you abstain from voting on this proposal, your vote will have no effect on the recommendation of the stockholders. If you sign and submit your proxy card without voting instructions, your shares will be voted FOR each director nominee and FOR Proposals 2 and 3, and ONE YEAR on Proposal 4.

 

Q:	What is the effect of broker non-votes?
A:	Shares that are held by brokers in “street name” may be voted by the broker on “routine” matters, such as ratification of Eide Bailly LLP as our independent registered public accounting firm for fiscal year 2025 (Proposal 2). To vote on “non-routine” matters, the broker must obtain stockholder direction. When the broker does not vote the shares, the broker’s abstention is referred to as a “broker non-vote.”   Broker non-votes will be considered present for quorum purposes at the 2025 Annual Meeting. Brokers do not have discretion to vote shares for the election of directors (Proposal 1), for the non-binding, advisory vote to approve named executive officer compensation (Proposal 3), for the non-binding, advisory recommendation on the frequency of votes on named executive officer compensation (Proposal 4), or for any other non-routine matters that may be brought before the 2025 Annual Meeting. Accordingly, if your shares are held in street name and you do not submit voting instructions to your broker, your shares will not be voted for these proposals. Broker non-votes in connection with the election of directors are not deemed “votes cast,” and, since directors are elected by a plurality of votes cast, will have no effect on the election. The shares underlying broker non-votes in connection with Proposal 3 and Proposal 4 will not be deemed entitled to vote and, therefore, these broker non-votes will have no effect on the outcome of this proposal.

 

 

	If you do not provide voting instructions, brokers will have discretion to vote on the ratification of Eide Bailly LLP as the Company’s independent registered public accounting firm for fiscal year 2025.   For any other business matters that may be brought before the 2025 Annual Meeting, the affirmative vote of a majority of the shares of the Company’s common stock present in person or by proxy at the 2025 Annual Meeting and entitled to vote on the matter is required to pass the proposal. Broker non-votes will be counted as present for quorum purposes at the 2025 Annual Meeting but will not be considered entitled to vote on non-routine matters and will therefore not be treated as affirmative or opposing votes.
Q:	How do I vote my shares?
A:	If you are a stockholder of record, you may vote your shares of common stock at the 2025 Annual Meeting using any of the following methods:

 

•

By proxy card. The enclosed proxy card is a means by which a stockholder may authorize the voting of such stockholder’s shares of common stock at the 2025 Annual Meeting. The shares of common stock represented by each properly executed proxy card will be voted at the 2025 Annual Meeting in accordance with the stockholder’s directions. The Company urges you to specify your choices by marking the appropriate boxes on the enclosed proxy card. After you have marked your choices, please sign and date the proxy card and return the proxy card in the enclosed envelope. If you sign and return the proxy card without specifying your choices, your shares will be voted FOR the five director nominees identified in Proposal 1; FOR each of Proposal 2 and Proposal 3; and for ONE YEAR with respect to Proposal 4.

 

•

Over the Internet. To vote by proxy over the Internet, go to http://www.proxyvote.com. Please have available the 16-Digit Control Number from the enclosed proxy card. Your vote must be received by 11:59 p.m., Eastern Daylight Time (10:59 p.m., CDT) on Tuesday, April 22, 2025, to be counted. We are providing Internet proxy voting to allow you to vote your shares via proxy online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your Internet access, such as usage charges from Internet access providers and telephone companies.

 

•

By telephone. To vote by proxy over the telephone, dial toll-free 1-800-690-6903 and follow the recorded instructions. Please have available the 16-Digit Control Number from the enclosed proxy card. Your vote must be received by 11:59 p.m., Eastern Daylight Time (10:59 p.m., CDT) on April 22, 2025, to be counted.

 

•

In person at the 2025 Annual Meeting. All stockholders of record as of March 7, 2025 may vote in person at the 2025 Annual Meeting. Even if you plan to attend the 2025 Annual Meeting, we recommend that you submit your proxy card ahead of time or vote over the Internet so that your vote can be counted if you later decide not to attend. In-person voting will not be available if you attend the 2025 Annual Meeting via teleconference.

 

You are a “beneficial owner” of shares held in “street name,” rather than a “stockholder of record,” if your shares are held in the name of a broker, bank, trust or other nominee as a custodian, and this Proxy Statement and the accompanying Notice were forwarded to you by that organization. As a beneficial owner, you have the right to direct your broker, bank, trust or other nominee how to vote your shares. You may vote by proxy by completing the voting instruction form provided by your custodian. Since a beneficial owner is not the stockholder of record, you may not vote your shares in person at the 2025 Annual Meeting unless you obtain a “legal proxy” from the broker, bank, trustee, or nominee that holds your shares giving you the right to vote the shares at the meeting.

 

Q:	Can I change my vote after I have mailed in my proxy card or voted over the Internet or by telephone?
A:	Proxies solicited by the Board of Directors may be revoked at any time prior to the 2025 Annual Meeting. No specific form of revocation is required. You may revoke your proxy by:

 

	•	Voting in person at the 2025 Annual Meeting;
	•	Returning a later-dated signed proxy card;
	•	Submitting a new vote by telephone or Internet; or

 

 

•

Giving personal or written notice of the revocation to the Company’s Chief Financial Officer, Michael Woods, at the commencement of the 2025 Annual Meeting.

 

If your shares are held in “street name” through a broker, bank, trustee, or other nominee, you will need to contact that custodian if you wish to change your voting instructions.

 

Q:	How will my shares be voted if I do not specify how they should be voted or if I vote for too few or too many choices on the proxy card?
A:	If you are a record holder and do not mark any choices for the election of directors on the proxy card, then the proxies solicited by the Board of Directors will be voted FOR the five nominees recommended for election by the Board of Directors. You may wish to vote for less than five director nominees. In such case, your shares will only be voted for the director nominee(s) you have selected. If you mark contradicting choices on the proxy card, such as both FOR and WITHHOLD for a director nominee, your shares will not be voted with respect to the director nominee for which you marked contradicting choices.   If you are a record holder and do not mark a choice with respect to the approval of any proposal other than the election of directors, then the proxies solicited by the Board of Directors will be voted FOR each of Proposal 2 and Proposal 3, and for ONE YEAR with respect to Proposal 4. If you mark contradicting choices on your proxy card, such as a mark both FOR and AGAINST the approval of a proposal, then your shares will not be counted either for or against the proposal for which you have marked contradicting choices.   If you are a street name holder and do not submit specific voting instructions to your broker, the organization that holds your shares may generally vote your shares with respect to “routine” items, but not with respect to “non-routine” items. On non-routine items for which you do not submit specific voting instructions to your broker, the shares will be treated as “broker non-votes.” Broker non-votes will be counted for purposes of determining whether a quorum is present. The proposal to ratify the appointment of Eide Bailly LLP as our independent registered public accounting firm (Proposal 2) is considered routine and therefore may be voted upon by your broker if you do not give instructions to your broker. However, brokers will not have discretion to vote your shares on Proposals 2, 3, or 4. Accordingly, if your shares are held in street name and you do not submit voting instructions to your broker, the broker non-votes will not be considered “votes cast” for purposes of determining the outcome of the election of director nominees and will have no effect on the outcome of the election. Similarly, the shares underlying broker non-votes on Proposal 3 and Proposal 4 will not be considered entitled to vote and will have no effect on the outcome of these proposals.

 

Q:	Who can attend the 2025 Annual Meeting?
A:	All stockholders of record as of the close of business on March 7, 2025, may attend the 2025 Annual Meeting. If you are not a stockholder of record but hold shares through a broker, bank, trustee, or other nominee as custodian (i.e., in “street name”), we may request proof of your beneficial ownership as of the record date, such as an account statement, a copy of the voting instruction card provided by your custodian, a “legal proxy” provided by your custodian, or other similar evidence of ownership.

 

Q:	What is the record date for the 2025 Annual Meeting?
A:	The Board of Directors has fixed Friday, March 7, 2025, as the record date.

 

Q:	Who will count the votes?
A:	All proxies submitted to the Company will be tabulated by Broadridge, a master tabulator service company. All shares voted by stockholders of record present in person at the 2025 Annual Meeting will be tabulated by our Chief Financial Officer.

 

Q:	Who is paying for this proxy solicitation?
A:	The entire cost of this proxy solicitation will be borne by the Company. The cost will include the cost of supplying necessary additional copies of the solicitation materials for beneficial owners of shares held of record by brokers, dealers, banks and voting trustees and their nominees and, upon request, the reasonable expenses of such record holders for completing the mailing of such materials to such beneficial owners. Our directors, executive officers and employees may, without compensation other than their regular remuneration, solicit proxies personally, by telephone, or electronically via the Internet.

 

 

Q:	How do I nominate a candidate for election as a director at next year’s annual meeting?
A:	You may recommend a candidate for nomination by the Board of Directors at next year’s annual meeting by following the procedures explained below in this Proxy Statement under the caption “CORPORATE GOVERNANCE – Selection of Director Nominees” and contained in the rules and regulations of the Securities and Exchange Commission (the “SEC”). You may directly nominate a candidate for election at next year’s annual meeting by following the procedures explained below in response to the question “When are stockholder proposals and director nominations due for next year’s annual meeting?”

 

Q:	What is a stockholder proposal?
A:	A stockholder proposal is your recommendation or requirement that the Company and/or the Board of Directors take action, which you intend to present at a meeting of the stockholders. Your proposal should state as clearly as possible the course of action that you believe the Company should follow. If your proposal is included in the Company’s proxy statement, then the Company must also provide the means for stockholders to vote on the matter via the proxy card. The deadlines and procedures for submitting stockholder proposals for next year’s annual meeting are explained in the following question and answer. The Company reserves the right to reject, rule out of order, or take appropriate action with respect to any proposal that does not comply with these and other applicable requirements.

 

Q:	When are stockholder proposals and director nominations due for the next year’s annual meeting?
A:	In order to be considered for inclusion in next year’s proxy statement, stockholder proposals must be submitted in writing to the Company no later than November 14, 2025 (approximately 120 days prior to the one-year anniversary of the mailing of this Proxy Statement). The Company suggests that proposals for next year’s annual meeting be submitted by certified mail, return receipt requested. The proposal must be in accordance with the provisions of Rule 14a-8 promulgated by the SEC under the Securities Exchange Act of 1934, as amended (the "Exchange Act").

 

	Stockholders who intend to present a proposal or director nomination at next year’s annual meeting without including such proposal or nomination in the Company’s proxy statement must, pursuant to the Company’s Bylaws, deliver to the Company notice of such proposal no earlier than January 23, 2026 (approximately 90 days prior to the one year anniversary of the 2025 Annual Meeting) and no later than February 20, 2026 (approximately 60 days prior to the one year anniversary of the 2025 Annual Meeting). The Company reserves the right to reject, rule out of order, or take appropriate action with respect to any proposal that does not comply with these and other applicable requirements.
	If a stockholder proposal intended to be submitted at next year’s annual meeting does not comply, as determined in the Chairman’s discretion, with the timeframes and other procedures established by the Company’s Bylaws, the proposal will be disregarded.

 

Q:	I reside at the same address as another stockholder. How do I receive my own copy of the proxy materials?

 

A:

The SEC has adopted rules that permit companies and brokers, banks and other nominees to satisfy the delivery requirements for proxy statements and annual reports, with respect to two or more stockholders sharing the same address and who do not participate in electronic delivery of proxy materials, by delivering a single copy of such documents addressed to those stockholders. This process, which is commonly referred to as “householding,” potentially means extra convenience for stockholders and cost savings for companies. Brokers, banks and other nominees may be “householding” Company proxy materials. This means that only one copy of the proxy materials may have been sent to multiple stockholders in a household. If, at any time, you no longer wish to participate in householding and would prefer to receive a separate proxy statement and annual report from the other stockholder(s) sharing your address, please: (i) notify your broker, bank or other nominee, (ii) direct your written request to our Chief Financial Officer, Art’s-Way Manufacturing Co., Inc., 5556 Highway 9, Armstrong, Iowa, 50514-0288, or (iii) contact us at (712) 208-8467. The Company will undertake to deliver promptly, upon any such oral or written request, a separate copy of the proxy materials to a stockholder at a shared address to which a single copy of these documents was delivered. Stockholders who currently receive multiple copies of proxy materials at their address and would like to request householding of their communications should notify their broker, bank or other nominee, or contact us at the above address or phone number.

 

 

PROPOSALS TO BE VOTED UPON

 

PROPOSAL 1

 

ELECTION OF DIRECTORS

 

What am I voting on? The Company’s Board of Directors (the “Board”) is asking our stockholders to elect each of the five director nominees named in this Proxy Statement to hold office until the 2025 Annual Meeting of Stockholders and until their successors are elected and qualified or until their earlier resignation or removal.   Board Recommendation: FOR the election of each of the five director nominees.   Required Vote: The five director nominees with the greatest number of shares voted FOR the director nominee will be elected.   Voting procedures and the method by which votes will be counted, including the treatment and effect of abstentions and broker non-votes, are more fully described above in the section titled “QUESTIONS AND ANSWERS ABOUT THE 2025 ANNUAL MEETING AND VOTING.”

 

Five members of the Board will be elected at the 2025 Annual Meeting to hold office until the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified or until their earlier resignation or removal. The Company has no reason to believe that any of the director nominees named below will be unable or unwilling to serve as director if elected. Each of the director nominees named below are each currently serving as a member of the Board.

 

The five nominees receiving the greatest number of affirmative votes cast will be elected as directors. Proxies cannot be voted for a greater number of persons than the number of nominees named. Except as otherwise directed on the proxy cards, the proxies will vote all valid proxies for the five nominees identified below. If for any reason any nominee withdraws or is unable to serve as director (neither of which is expected at this time), the shares represented by all valid proxies will be voted for the election of a substitute nominee recommended by the Board or the Board may reduce the size of the Board.

 

Nominees for Election as Directors at the 2025 Annual Meeting

 

The Board has recommended the following persons as nominees for election as directors at the 2025 Annual Meeting:

 

Nominee Name	Age (as of Annual Meeting)	Year First Became a Director
Marc H. McConnell	46	2001
Thomas E. Buffamante	72	2003
David A. White	72	2016
Matthew N. Westendorf	54	2021
Randall C. Ramsey	62	2022

 

Certain biographical information relating to each of the director nominees is set forth below:

 

MARC H. McCONNELL, Chairman, Director, President and Chief Executive Officer. In addition to his roles with the Company, Mr. McConnell is currently the President of Bauer Corporation and McConnell Holdings, Inc. Mr. McConnell previously served as the Chairman of the Board, Chairman of the Audit Committee, and Chairman of the Executive Committee of Integrated Financial Holdings, Inc., a financial holding company headquartered in Raleigh, North Carolina. Mr. McConnell had served as a director of Integrated Financial Holdings, Inc. and/or its subsidiary bank, West Town Bank & Trust, since 2009. Effective October 1, 2024, Mr. McConnell was appointed to the board of directors of Capital Bancorp, Inc. following the merger of Integrated Financial Holdings, Inc. with and into Capital Bancorp, Inc. Mr. McConnell also serves on the board of directors of Capital Bank, N.A., which is a wholly owned subsidiary of Capital Bancorp, Inc. with its main office in Rockville, Maryland. Capital Bancorp, Inc. is a Nasdaq-listed company with a class of securities registered pursuant to Section 12 of the Exchange Act. From May 2019 until August 2024, Mr. McConnell served as a director of Dogwood State Bank, a North Carolina state-chartered bank with its main office in Raleigh, North Carolina. Mr. McConnell has served as a director of the American Ladder Institute since 2004 and served as its President from 2006 to 2010. Mr. McConnell was also named a director of the Farm Equipment Manufacturers Association in October 2007, served as its President from 2013 to 2014 and served as its Treasurer from October 2015 to October 2016. Mr. McConnell was appointed to our Board in July 2001 and served as Vice Chairman of the Board from January 2008 to April 2015, at which time he became our Chairman. He currently resides in Raleigh, North Carolina. Among other attributes, skills, and qualifications, the Board believes that Mr. McConnell’s involvement and experience in the farm equipment manufacturing industry, particularly in leadership positions with similarly situated companies, contribute to his ability to understand the challenges and opportunities facing the Company and to guide its long-term strategies.

 

 

THOMAS E. BUFFAMANTE, Director. Mr. Buffamante is a Certified Public Accountant and Director of Buffamante Whipple Buttafaro, P.C., where he has been a director and stockholder since 1981. Mr. Buffamante has been a director of the Company since 2003, was appointed to our Audit Committee in 2011, and has served as the Chairman of the Audit Committee since April 2012. He currently resides in Great Valley, New York. Among other attributes, skills, and qualifications, the Board believes that Mr. Buffamante is qualified to serve as a director in light of his ability to understand generally accepted accounting principles, internal control over financial reporting, and disclosure controls and procedures, his experience in analyzing and evaluating financial statements, and his ability to provide oversight with regard to tax filings, tax accruals, and other tax matters.

 

DAVID A. WHITE, Director. Mr. White is a corporate director and currently the General Partner of First Call Services LLC, a private holding company and advisory firm. He has held a number of senior financial and operating positions with John Labatt Limited, Lawson Mardon Group Inc., and Laidlaw Inc., and was Chief Executive Officer of American Student Transportation Partners, a provider of student transportation services, Chief Executive Officer of TransCare Inc., a medical transportation company, and President and Chief Operating Officer of Student Transportation of America, formerly a TSX-listed company. He also serves on the board of directors for Ag Growth International Inc., a Toronto Stock Exchange-listed farm equipment manufacturer. Mr. White has been a Canadian Charted Accountant since 1978, he holds a BA from the University of Western Ontario and an MBA from the University of Toronto, and in 2013 he received the ICD.D designation from the Institute of Corporate Directors. Mr. White was appointed to the Board in December 2016 and currently serves as a member of the Audit and Chair of the Compensation Committees. Among other attributes, skills, and qualifications, the Board believes that Mr. White is qualified to serve as a director in light of his involvement and experience in the farm equipment manufacturing industry, board experience, his ability to understand generally accepted accounting principles, internal control over financial reporting, and disclosure controls and procedures, his experience in analyzing and evaluating financial statements, and management experience.

 

MATTHEW N. WESTENDORF, Director. Mr. Westendorf is the current President of Westendorf Manufacturing Co., Inc., a manufacturing of front-end loaders located in Onawa, Iowa, a position he has held since 2006. He previously served on the executive board of the Farm Equipment Manufacturers Association from 2014-2023 (President 2021) and on the board of directors of Jack Rabbit Manufacturing. Mr. Westendorf was appointed to our Board in April 2021. Among other attributes, skills, and qualifications, the Board believes that Mr. Westendorf’s experience running a manufacturing company allows him to provide insight into the Company’s operations and strategic direction.

 

RANDALL C. RAMSEY, Director. Mr. Ramsey is the founder and former president of Jarrett Bay Boatworks, a position he held from 1986 to 2022. Mr. Ramsey is currently the vice president of operations of Safe Harbor Jarrett Bay. He is also a former principal and board member of Bluewater Yacht Sales, a company formed through the merger of Jarrett Bay Yacht Sales and Bluewater Yacht Sales in 2012. Mr. Ramsey serves on the board of governors for the University of North Carolina System and was a past Vice Chair (2018-2019) and Chairman (2019-2024). He has served on the Big Rock Blue Marlin Tournament's board since 1987, serving as President for two terms and is on the boards of other private companies. His past board membership includes the North Carolina Manufacturer's Association and the American Boat Builders & Repairers Association, as well as serving as a director for federally and state-regulated financial institutions. Mr. Ramsey previously served as President of The North Carolina State University Student Aid Association and is a past member of the North Carolina State University Board of Trustees. Mr. Ramsey was appointed to our Board in April 2022. Among other attributes, skills and qualifications, the Board believes that Mr. Ramsey’s vast business experience in leadership and business operations provides insight into the future growth and strategic directions of the Company.

 

 

PROPOSAL 2

 

RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

What am I voting on? The Board is asking our stockholders to ratify its selection of Eide Bailly LLP as our independent registered public accounting firm for the fiscal year ending November 30, 2025.   Voting Recommendation: FOR the ratification of our independent registered public accounting firm.   Vote Required: Ratification requires an affirmative vote of the majority of shares present in person or represented by proxy and entitled to vote.   Voting procedures and the method by which votes will be counted, including the treatment and effect of abstentions and broker non-votes, are more fully described above in the section titled “QUESTIONS AND ANSWERS ABOUT THE 2025 ANNUAL MEETING AND VOTING.”

 

The Board, acting on the recommendation of the Audit Committee, has selected Eide Bailly LLP as the Company’s independent registered public accounting firm for fiscal year 2025. Eide Bailly LLP has been the Company’s independent registered public accounting firm since July 2006. Eide Bailly LLP has advised the Company that it has no relationship to the Company except that of independent registered public accounting firm. A representative of Eide Bailly LLP is expected to be present at the 2025 Annual Meeting. Such representative will have an opportunity to make a statement if the representative desires to do so and will be available to respond to appropriate questions regarding audit of the financial statements.

 

Audit Fees 

 

The following table presents fees for professional services billed by Eide Bailly LLP to the Company for the audit of the Company’s annual financial statements, the review of the Company’s interim financial statements, and related services for the fiscal years ended November 30, 2024 and November 30, 2023.

 

Category	Fiscal Year	Fees ($)
Audit Fees (1)	2024	142,800
	2023	138,006
Audit-Related Fees (2)	2024	-
	2023	-
Tax Fees (3)	2024	23,625
	2023	24,938
All Other Fees	2024	-
	2023	-

 

(1)	Audit fees represent fees billed for each of the last two fiscal years for professional services provided for the audit of the Company’s annual financial statements and review of the Company’s quarterly financial statements in connection with the filing of current and periodic reports.

 

(2)	Audit-related fees represent fees for assurance and related services that are reasonably related to the performance of the audit or review of the Company’s financial statements.

 

(3)	Tax fees represent fees billed for each of the last two fiscal years for tax compliance, tax advice and tax planning, which included preparation of tax returns. 2024 is an estimate based on the engagement letter as these services are not yet completed.

 

Audit Committee Pre-Approval Policies and Procedures

 

The Audit Committee pre-approved the engagement of Eide Bailly LLP as the Company’s principal independent registered public accounting firm to perform audit services for the Company. The Audit Committee pre-approves all auditing services and permitted non-audit services, including the fees and terms of those services, to be performed for the Company by its independent registered public accounting firm prior to engagement. One hundred percent of the services referenced above were pre-approved by our Audit Committee.

 

 

PROPOSAL 3

 

APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF NAMED EXECUTIVE OFFICER COMPENSATION

 

What am I voting on? The Board is asking our stockholders to approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers disclosed in this Proxy Statement.   Voting Recommendation: FOR the approval of the compensation of the named executive officers.   Vote Required: Approval requires an affirmative vote of the majority of shares present in person or represented by proxy and entitled to vote.   Voting procedures and the method by which votes will be counted, including the treatment and effect of abstentions and broker non-votes, are more fully described above in the section titled “QUESTIONS AND ANSWERS ABOUT THE 2025 ANNUAL MEETING AND VOTING.”

 

The Dodd-Frank Wall Street Reform and Consumer Protection Act and Section 14A of the Exchange Act require that the Company provide its stockholders with the opportunity to vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in this Proxy Statement in accordance with the compensation disclosure rules of the SEC. In accordance with the preference of our stockholders, as expressed in a non-binding, advisory vote on the frequency of votes on named executive officer compensation at our 2019 Annual Meeting of Stockholders, the Company previously determined to hold annual votes on the approval of compensation of the Company’s named executive officers.

 

We seek to closely align the interests of our named executive officers with the interests of our stockholders. We designed our compensation program to reward our named executive officers for individual performance and contributions to our overall business objectives and for achieving and surpassing the financial goals set by our Compensation Committee and our Board.

 

The vote on this resolution is not intended to address any specific element of compensation. Instead, the vote relates to the overall compensation of our named executive officers, as described in this Proxy Statement, in accordance with the compensation disclosure rules of the SEC.

 

Accordingly, we ask our stockholders to approve the following resolution at the 2025 Annual Meeting:

 

“RESOLVED, that the Company’s stockholders approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Company’s Proxy Statement for the 2025 Annual Meeting of Stockholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the summary compensation table and the other related tables and disclosure.”

 

While the Board and the Compensation Committee intend to carefully consider the results of this vote when making future decisions regarding the compensation of our named executive officers, this vote is not binding on the Company or the Board and is advisory in nature. To the extent there is any significant vote against the compensation of our named executive officers, the Board and the Compensation Committee will evaluate what actions may be necessary to address our stockholders’ concerns.

 

 

PROPOSAL 4

 

RECOMMENDATION, ON A NON-BINDING, ADVISORY BASIS, OF THE FREQUENCY OF VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION

 

What am I voting on? The Board is asking our stockholders to recommend, on a non-binding, advisory basis, how frequently the Board should seek future votes on the compensation of the Company’s named executive officers.   Voting Recommendation: For ONE YEAR as the frequency for future votes on the compensation of the named executive officers.   Vote Required: The alternative receiving the greatest number of votes relative to the votes cast for the other alternatives will be deemed the alternative recommended by the stockholders.   Voting procedures and the method by which votes will be counted, including the treatment and effect of abstentions and broker non-votes, are more fully described above in the section titled “QUESTIONS AND ANSWERS ABOUT THE 2025 ANNUAL MEETING AND VOTING.”

 

The Dodd-Frank Wall Street Reform and Consumer Protection Act and Section 14A of the Exchange Act also provide that stockholders must be given the opportunity to vote, on a non-binding, advisory basis, for their preference as to how frequently we should seek votes on the compensation of our named executive officers as disclosed in accordance with the SEC’s compensation disclosure rules. In accordance with the preference of our stockholders, as expressed in a non-binding, advisory vote on the frequency of votes on named executive officer compensation at our 2019 Annual Meeting of Stockholders, the Company previously determined to hold annual votes on the compensation of named executive officers.

 

Stockholders may indicate whether they would prefer that we conduct future non-binding, advisory votes on named executive officer compensation once every one, two, or three years. Stockholders also may, if they wish, abstain from casting a vote.

 

After careful consideration, the Board recommends annual non-binding, advisory votes on the compensation of the Company’s named executive officers. The Board believes that annual votes will provide the clearest and most useful feedback from stockholders to the Company, the Board, and the Compensation Committee in this important area and will confirm the Company's commitment to frequent and transparent communications with its stockholders.

 

While the Board and the Compensation Committee intend to carefully consider the results of this vote when making decisions regarding the frequency of future non-binding, advisory votes on the approval of our named executive officers compensation, this vote is not binding on the Company or the Board and is advisory in nature.

 

 

OTHER INFORMATION

 

CORPORATE GOVERNANCE

 

Our Board currently has five members: Thomas E. Buffamante, Randall C. Ramsey, David A. White, Matthew N. Westendorf and Marc H. McConnell. Pursuant to the Company’s Bylaws, the Board has set the size of the Board at five directors as of the 2025 Annual Meeting.

 

All of our current directors are “independent” within the definition provided by Nasdaq Rule 5605, with the exception of Marc McConnell. The Board has determined that Marc McConnell is not independent because he is an officer of the Company serving in the role of President and Chief Executive Officer.

 

The Board held four formal meetings during the fiscal year ended November 30, 2024 (“fiscal year 2024”) and two impromptu update calls. Each director attended in person or via teleconference 100% of the total number of Board meetings held while the director served during fiscal year 2024 and the total number of meetings held by all committees of the Board on which the director served during fiscal year 2024, with the exception of Randy Ramsey who missed the March 2024 Board of Director’s update call. The Board encourages all directors to attend the Company’s annual meeting of stockholders but does not have a formal attendance policy. The Company’s last annual meeting of stockholders held on April 23, 2024 was attended in person or via teleconference by each of the directors who were serving at that time.

 

The Board has an Audit Committee and a Compensation Committee. The Board as a whole functions as the Company’s Nominating and Governance Committee, although director nominees are recommended by our independent directors without participation of the non-independent directors.

 

The Board’s Role in Risk Oversight

 

Management has the responsibility to manage risk and bring to the Board’s attention the most material risks to the Company. The Board has oversight responsibility of the processes established to report and monitor systems for material risks applicable to the Company. The Audit Committee provides oversight of management with respect to enterprise-wide risk management, which focuses primarily on risks relating to commodity pricing (such as steel), the Company’s ability to maintain appropriate levels of credit and insurance coverage, and financial and accounting, legal and compliance risks, including oversight of inventory accounting, revenue recognition, and other internal controls over financial reporting. In addition, the Compensation Committee considers risks related to the attraction and retention of talent and risks relating to the design of compensation programs and arrangements. The Compensation Committee reviews compensation and benefits plans affecting all employees, including the executive officers. We have determined that it is not reasonably likely that our compensation and benefit plans create risks that would have a material adverse effect on the Company. The full Board considers strategic risks and opportunities and regularly receives detailed reports from management and the committees with respect to their areas of responsibility for risk oversight.

 

Board Leadership Structure

 

On October 4, 2024, our Chairman, Marc McConnell, was appointed to the role of President and Chief Executive Officer, following the departure on October 1, 2024, of David A. King, who previously served as our principal executive officer. Given (i) Mr. McConnell’s long tenure with, and institutional knowledge, of the Company, (ii) the Company’s small size relative to other publicly traded companies, and (iii) the Company’s ongoing efforts to control costs, the Company determined this leadership structure was in the Company’s best interest, rather than separating the roles of chairman of the board and principal executive officer. 

 

Because the Board has determined that Mr. McConnell does not satisfy the definition of “independence” as set forth in Nasdaq Rule 5605, the Board appointed Randall C. Ramsey to serve as “presiding director” over all executive sessions of independent directors that are required under Nasdaq rules. Mr. Ramsey has served in the presiding director role since 2025. 

 

 

Code of Ethics

 

The Company has adopted a Code of Ethics (the “Code”), which is applicable to all directors, officers and employees of the Company. The Code covers all areas of professional conduct, including customer and supplier relationships, conflicts of interest, insider trading, confidential information, accuracy of company records, public disclosures, contact with government officials, and workplace behavior. It requires strict adherence to all laws and regulations applicable to our business. Persons who are subject to the Code are required to bring any violations and suspected violations of the Code to the Company’s attention, through their supervisor, management, outside legal counsel, or confidential communication with the Chairman of the Audit Committee.

 

The Code of Ethics is posted to our website at http://www.artsway-mfg.com/corporate-governance/. We intend to include on our website, within the time period required by Form 8-K, any amendment to, or waiver from, a provision of our Code of Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer, controller, or persons performing similar functions, that relates to any element of the Code of Ethics definition enumerated in Item 406(b) of Regulation S-K.

 

Audit Committee

 

The principal functions of the Audit Committee are to evaluate and review the Company’s financial reporting process and systems of internal controls. The Audit Committee evaluates the independence of the Company’s independent registered public accounting firm, recommends selection of the Company’s independent registered public accounting firm to the Board, approves fees to be paid to our independent registered public accounting firm, and reviews the Company’s financial statements with management and the independent registered public accounting firm. The Audit Committee has recommended to the Board the appointment of Eide Bailly LLP to serve as the Company’s independent registered public accounting firm for fiscal year 2025.

 

The Audit Committee operates under a written charter, which is available on our website at http://www.artsway-mfg.com/corporate-governance/. Under the charter, the Audit Committee must consist of not less than three members of the Board and its composition must otherwise satisfy Nasdaq requirements applicable to audit committees. During fiscal year 2024, the members of the Audit Committee were Thomas E. Buffamante (Chairman), Matthew Westendorf and David A. White. Messrs. Buffamante, Westendorf and White will continue to serve as members of the Audit Committee in fiscal year 2025. The Board has determined that all current and proposed members of the Audit Committee are independent under the definition of “independence” provided by Nasdaq Rule 5605 and Rule 10A-3 of the Exchange Act. The Board has also determined that Mr. Buffamante and Mr. White are each an “audit committee financial expert” as defined by applicable SEC regulations, and that all members of the Audit Committee are financially literate as required by Nasdaq Rule 5605. The Audit Committee held 5 meetings during fiscal year 2024 (including a pre-audit planning meeting).

 

Report of the Audit Committee

 

The following report of the Audit Committee shall not be deemed to be filed with the SEC or incorporated by reference in any previous or future documents filed by the Company with the SEC under the Securities Act of 1933 or the Exchange Act, except to the extent that the Company specifically incorporates the reference in any such document.

 

The Audit Committee reviews the Company’s financial reporting process on behalf of the Board. Management has the primary responsibility for the financial statements and the reporting process. The Company’s independent registered public accounting firm is responsible for performing an independent audit of the Company’s financial statements and expressing an opinion on the conformity of the audited financial statements to generally accepted accounting principles.

 

The members of the Audit Committee have reviewed and discussed with management the Company’s audited financial statements as of and for the fiscal year ended November 30, 2024. The members of the Audit Committee have discussed with Eide Bailly LLP, the Company’s independent registered public accounting firm, the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board and the Securities and Exchange Commission. The members of the Audit Committee have received and reviewed the written disclosures and the letter required by applicable requirements of the Public Company Accounting Oversight Board regarding communications with the audit committee concerning independence, and the members of the Audit Committee have discussed with Eide Bailly LLP their independence from management and the Company. The members of the Audit Committee have considered whether the provision of services by Eide Bailly LLP referred to above not related to the audit of the financial statements and the reviews of the interim financial statements included in the Company’s Forms 10-Q are compatible with maintaining Eide Bailly LLP’s independence, and have determined that they are compatible and do not impact Eide Bailly LLP’s independence.

 

 

Based on the reviews and discussions referred to above, the Audit Committee recommended to the Board that the audited financial statements referred to above should be included in our Annual Report on Form 10-K accompanying this Proxy Statement and filed with the SEC for the fiscal year ended November 30, 2024.

 

Audit Committee

 

Thomas E. Buffamante, Chairman

Matthew N. Westendorf

David A. White

 

Compensation Committee

 

During fiscal year 2024, the members of the Compensation Committee were David A. White (Chairman), Thomas E. Buffamante and Matthew Westendorf. Messrs. Buffamante, Westendorf and White will serve as members of the Compensation Committee for fiscal year 2025. The Board has determined that all current and proposed members of the Compensation Committee are independent within the definition of “independence” provided by Nasdaq Rule 5605 and Rule 10C-1 of the Exchange Act. The Compensation Committee operates under a written charter, which is available on our website at http://www.artsway-mfg.com/corporate-govemance/. Under the charter, the Compensation Committee must consist of two or more members of the Board, and each member must meet applicable Nasdaq independence standards.

 

The Board has authorized the Compensation Committee to review and advise management on a broad range of compensation policies, such as salary ranges and incentive programs for employees, although the Company’s Chief Executive Officer is responsible for establishing specific terms of compensation for Company employees who are not subject to Section 16 of the Exchange Act. The Compensation Committee reviews and makes recommendations to the Board as to the compensation of those Company employees who are subject to Section 16 of the Exchange Act, which includes the Chief Executive Officer and Chief Financial Officer. The Board retains the authority to set director compensation, each based on the Compensation Committee’s recommendations. Marc McConnell does not participate in the discussion or approval of the payments he receives from the Company as compensation for services he provides as the Company’s President, Chief Executive Officer, and Chairman of the Board.

 

Although the Board administers the Company’s equity incentive plans, the Compensation Committee remains responsible for recommending to the Board any equity awards to the Company’s Chairman, Chief Executive Officer and the Chief Financial Officer, and the Board may delegate to the Compensation Committee additional administrative duties for the equity incentive plans in the future. Neither the Compensation Committee nor the Board engages compensation consultants to assist in determining or recommending the amount or form of compensation for executive officers or directors. Executive officers do not have any role in determining or recommending the amount or form of executive officer or director compensation. The Compensation Committee may delegate its responsibilities to subcommittees to the extent permitted by applicable laws and regulations; however, such subcommittees are not permitted to have decision-making authority and are required to report regularly to the full Compensation Committee. The Compensation Committee had one meeting during fiscal year 2024.

 

Nominating and Governance Committee

 

The Board as a whole performs the functions of a Nominating and Governance Committee, with only our independent directors participating in the recommendation to our full Board regarding director nominees. The Board has determined that each of our directors is independent under the definition of “independence” provided by Nasdaq Rule 5605, with the exception of Marc McConnell for the reasons identified above. Because a majority of our directors are independent, the Board does not deem it necessary to have a separate Nominating and Governance Committee. In accordance with Nasdaq requirements, all five of the director nominees for the 2025 Annual Meeting were recommended by a majority of the independent directors without participation of the non-independent director. The Board met once during fiscal year 2024 for the purpose of evaluating candidates for director nominees.

 

The principal purpose of the Board, acting as the Nominating and Governance Committee, is to identify and evaluate qualified individuals for membership on the Board. The Board annually considers the size, composition and needs of the Board in evaluating director candidates and recommends director nominees for election at each annual meeting of stockholders. The Board operates as the Nominating and Governance Committee pursuant to a written charter, which is available on our website at http://www.artsway-mfg.com/corporate-governance/.

 

 

Selection of Director Nominees

 

In selecting nominees for directors, the Board, acting as the Nominating and Governance Committee, will consider all candidates submitted, including incumbent Board members, based upon the qualifications of the candidates, the business and financial experience of the candidates, the experience of the candidates serving on public company boards of directors, and other skill sets deemed appropriate by the Board to enact the mission and business purposes of the Company. Our Criteria and Policies for Director Nominations (the “Nominations Policies”) were adopted by the Board, acting as the Nominating and Governance Committee, and are included in the Nominating and Governance Committee Charter. The Nominations Policies specify that directors must have certain minimum qualifications, including the ability to read and understand basic financial statements, familiarity with the Company’s business and industry, high moral character and mature judgment and the ability to work collegially with others.

 

Diversity is also a factor in evaluating director nominees. The Board values the benefits that diversity can bring and seeks to maintain a Board comprised of talented and dedicated directors. The Nominations Policies do not restrict the criteria that the Board may consider when evaluating diversity. The Board typically considers diversity of experience, skill, geographic representation and background as factors in the selection of new director nominees, with the goal of assembling a board of directors with complementary skill sets and viewpoints. The Board has not adopted a standalone diversity policy at this time. Nominees are not discriminated against on the basis of race, religion, national origin, sexual orientation, disability or any other basis proscribed by law.

 

Currently, the Company does not engage any third parties, for a fee or otherwise, to identify or evaluate potential nominees. The Board will consider director candidates recommended by holders of the Company’s common stock on the same basis as any other candidate submitted for consideration as a nominee. No nominations for candidates were received from any holders of common stock for the 2025 Annual Meeting.

 

In order for a candidate to be considered for nomination by the Board, a stockholder must submit to the attention of the Chief Executive Officer of the Company a written recommendation that contains the following information:

 

	(1)	the full name and address of the stockholder or group submitting the recommendation;
	(2)	the number of shares of common stock of the Company owned by the stockholder or group submitting the recommendation, and the date such shares were acquired;
	(3)	the full name and address of the director nominee;
	(4)	the age of the director nominee;
	(5)	a five-year business history of the director nominee;
	(6)	the amount of common stock of the Company owned by the director nominee;
	(7)	whether the director nominee can read and understand basic financial statements;
	(8)	the director nominee’s other board memberships, if any;
	(9)	any family relationships between the director nominee and any executive officer or current director of the Company;
	(10)	any business transactions between the director nominee or the candidate’s business and the Company;
	(11)	a written consent of the director nominee to be named in the Company’s proxy statement and to serve as a director if elected; and
	(12)	a written consent of the stockholder or group to be named in the Company’s proxy statement.

 

Additionally, any holder of common stock nominating a candidate is encouraged to set forth any other qualifications which such stockholder believes the candidate has to serve as director of the Company and the reasons why the stockholder believes the candidate should be elected to the Board. The Board may require the stockholder or nominee to furnish additional information to evaluate the nominee’s suitability. In the event a stockholder does not comply with the nomination process described in this Proxy Statement, the proposed nomination may be declared defective and disregarded.

 

Pursuant to the Company’s Bylaws, stockholders who intend to present a floor proposal or director nomination at the 2026 Annual Meeting of Stockholders without including such proposal or nomination in the Company’s proxy statement must deliver to the Company notice of such proposal no earlier than January 23, 2026 (approximately 90 days prior to the one year anniversary of the 2025 Annual Meeting) and no later than February 20, 2026 (approximately 60 days prior to the one year anniversary of the 2025 Annual Meeting); provided, however, that in the event that the date of the 2026 annual meeting is advanced by more than thirty (30) days or delayed by more than sixty (60) days from such anniversary date, notice by the stockholder to be timely must be so delivered not earlier than the ninetieth (90th) day prior to such annual meeting and not later than the close of business on the later of the sixtieth (60th) day prior to such annual meeting or the tenth (10th) day following the day on which public announcement of the date of such meeting is first made. The Company reserves the right to reject, rule out of order, or take appropriate action with respect to any proposal that does not comply with these and other applicable requirements.

 

 

In addition to satisfying the requirements under our Bylaws, to comply with the universal proxy rules, a person who intends to solicit proxies in support of director nominees other than the Company’s nominees must provide notice to the Company that sets forth the information required by Rule 14a-19(b) under the Exchange Act, including a statement that such person intends to solicit the holders of shares representing at least 67% of the voting power of the Company’s shares entitled to vote in the election of directors in support of director nominees other than the Company’s nominees.

 

For additional information regarding stockholder proposals, please see the above response to the question “When are stockholder proposals and director nominations due for next year’s annual meeting?”

 

Anti-Hedging Policy

 

While we have not adopted a written anti-hedging policy, our directors and named executive officers have confirmed that they have not engaged in transactions to hedge or offset decreases in the market value of our common stock, including short-selling, put or call options, forward sale or purchase contracts, equity swaps, and exchange funds.

 

Policy Prohibiting Insider Trading and Related Procedures

 

We have adopted an insider trading policy governing the purchase, sale, and other dispositions of our securities by directors, officers, and employees. The Company does not transact in its own securities if it is aware of material nonpublic information about the Company. We believe our insider trading policies and procedures are reasonably designed to promote compliance with insider trading laws, rules, and regulations, and Nasdaq listing standards. A copy of the insider trading policy is filed as Exhibit 19.1 to our Annual Report on Form 10-K for the fiscal year ended November 30, 2024.

 

SECURITY HOLDER COMMUNICATIONS TO THE BOARD OF DIRECTORS

 

Any holder of common stock wishing to communicate with the Board about any matter involving the business or operations of the Company should send the communication, in written form, to the Chief Executive Officer of the Company at the Company’s principal place of business at 5556 Highway 9, Armstrong, Iowa, 50514-0288. The Chief Executive Officer of the Company will promptly send the communication to each member of the Board or, if applicable, specified individual directors.

 

 

SECURITY OWNERSHIP OF DIRECTORS, EXECUTIVE OFFICES AND PRINCIPAL STOCKHOLDERS

 

The following table shows certain information with respect to the Company’s common stock beneficially owned by current directors, director nominees, and executive officers of the Company as of March 7, 2025, as well as the name and address of the persons known to the Company who beneficially own more than 5% of the issued and outstanding shares of common stock of the Company as of March 7, 2025. The shares shown as beneficially owned include shares that executive officers, directors, and director nominees are entitled to acquire pursuant to outstanding stock options exercisable within 60 days of March 7, 2025. Unless otherwise provided, the address of each of the executive officers, directors, and director nominees listed below is c/o Art’s-Way Manufacturing Co., Inc., 5556 Highway 9, Armstrong, Iowa, 50514-0288.

 

Name of Beneficial Owner	Position		Amount and Nature of Beneficial Ownership (1)				Percent of Class (2)
5% Stockholders
McConnell Legacy Investments LLC (3)	Stockholder			2,149,819	(3)			42.3	%
Directors and Officers
Thomas E. Buffamante	Director			54,000	(4)			1.1	%
Marc H. McConnell	Chairman, President and CEO			2,380,899	(5)			46.8	%
Randall C. Ramsey	Director			60,909				1.2	%
Matthew Westendorf	Director			20,000				-
David A. White	Director			40,000	(6)			-
David A. King	Former President and CEO (7)			83,544				1.6	%
Michael Woods	Chief Financial Officer			44,189				-
Directors and Executive Officers as a Group (7 individuals)				2,683,541				52.8	%

* Less than 1%

 

(1)	Number reported indicates shares and is determined in accordance with SEC rules and generally includes holding, voting and investment power with respect to the securities. Unless otherwise noted, the stockholders listed in the table have sole voting and investment power with respect to the shares indicated.
(2)	Based on 5,086,584 shares issued and outstanding as of March 7, 2025.
(3)	Marc McConnell is the managing member of McConnell Legacy Investments LLC and has voting control of the securities held by such entity.
(4)	Includes 5,000 shares held individually, 47,000 shares held jointly with spouse, and 2,000 shares of common stock underlying stock options that can be exercised within 60 days of March 7, 2025.
(5)	Includes 214,500 shares of common stock held by Mr. McConnell; 2,149,819 shares held by McConnell Legacy Investments LLC, of which Mr. McConnell is the managing member and holds voting control; 10,000 shares of common stock held indirectly by Mr. McConnell’s children; 5,580 shares of common stock held in individual retirement accounts, over which Mr. McConnell has voting and dispositive power; and 2,000 shares of common stock underlying stock options that can be exercised within 60 days of March 7, 2025.
(6)	Includes 40,000 owned jointly with spouse.

 

EXECUTIVE OFFICERS

 

Marc H. McConnell, age 46 (as of annual meeting date), is currently serving as our President and Chief Executive Officer, a position he has held since October 4, 2024. Mr. McConnell is also the Chairman of the Board, a role he has held since 2015, and has served on our board of directors since July 2001. In addition to his roles with the Company, Mr. McConnell is currently the President of Bauer Corporation and McConnell Holdings, Inc. Mr. McConnell previously served as the Chairman of the Board, Chairman of the Audit Committee, and Chairman of the Executive Committee of Integrated Financial Holdings, Inc., a financial holding company headquartered in Raleigh, North Carolina. Mr. McConnell had served as a director of Integrated Financial Holdings, Inc. and/or its subsidiary bank, West Town Bank & Trust, since 2009. Effective October 1, 2024, Mr. McConnell was appointed to the board of directors of Capital Bancorp, Inc. following the merger of Integrated Financial Holdings, Inc. with and into Capital Bancorp, Inc. Mr. McConnell also serves on the board of directors of Capital Bank, N.A., which is a wholly owned subsidiary of Capital Bancorp, Inc. with its main office in Rockville, Maryland. Capital Bancorp, Inc. is a Nasdaq-listed company with a class of securities registered pursuant to Section 12 of the Exchange Act. From May 2019 until August 2024, Mr. McConnell served as a director of Dogwood State Bank, a North Carolina state-charted bank with its main office in Raleigh, North Carolina. Mr. McConnell has served as a director of the American Ladder Institute since 2004 and served as its President from 2006 to 2010. Mr. McConnell was also named a director of the Farm Equipment Manufacturers Association in October 2007, served as its President from 2013 to 2014 and served as its Treasurer from October 2015 to October 2016.

 

Michael Woods, age 38 (as of annual meeting date), is currently serving as our Chief Financial Officer, a position he has held since February 1, 2020. Mr. Woods joined the Company in April 2016 and served as a Senior Staff Accountant and as the Controller until his promotion to Vice President of Finance in January 2019. Mr. Woods began his career in 2012 with Brinkman & Reed, CPAs in Estherville, IA as a Staff Accountant where he performed compilations, reviews, audits and tax consulting services. After three years in public accounting, he spent a year and a half as a Senior Staff Accountant with XPO Logistics (formerly Norbert Dentressangle) in Clive, Iowa. Mr. Woods received Bachelor of Science Degrees in Accounting and Finance from Iowa State University and has been a Certified Public Accountant since October of 2013. Mr. Woods is also a Certified Valuation Analyst as governed by the National Association of Certified Valuators and Analysts since June of 2023.

 

 

EXECUTIVE COMPENSATION²

 

The compensation philosophy of the Company is to provide a compensation package to executive officers that will maximize long-term stockholder value. The components of executive officer compensation are base salary, cash incentive compensation and equity awards.

 

The Company’s policy is to pay base salaries that are at, or near, the average base salary for similar companies. The Compensation Committee annually determines whether to recommend to the Board salary increases for the Company’s executive officers, which recommendation is based on current salaries and individual and Company performance during the past year. Other components of officer compensation are generally also reviewed annually.

 

The Board has an incentive compensation pool and incentive compensation plans for the Chairman of the Board, Chief Executive Officer and Chief Financial Officer, and certain other key employees. The objectives and the target incentive compensation thresholds and gradations pursuant to the pool and plans are based on an analysis of market data conducted by the Compensation Committee, along with consideration of the Company’s circumstances and opportunities. They reflect the belief of the Board and Compensation Committee that defined annual incentives should be closely aligned with financial performance and opportunities for long-term growth.

 

Under the approved incentive arrangements, the applicable possible maximum cash incentives for fiscal year 2024 were as follows: Marc McConnell, $93,713 (35% of annual base retainer); David King, $96,250 (35% of annual base salary); Michael Woods, $30,450 (20% of annual base salary). The relevant objectives for fiscal year 2024 pertaining to the Chairman were achievement of EBITDA targets for fiscal year 2024, debt retirement and successful oversight of other business development activities. The relevant objectives for fiscal year 2024 pertaining to the Chief Executive Officer and Chief Financial Officer were achievement of EBITDA targets for fiscal year 2024 and defined strategic company objectives. David King was no longer employed as of bonus payout date so received no incentive compensation related to 2024 objectives while Michael Woods received $15,225. In addition to the incentive compensation, the Board also approved discretionary bonuses to Marc McConnell ($30,000), in recognition of debt retirement and strategic leadership in agriculture downturn, and to Michael Woods ($19,775) for leadership during CEO transition.

 

The maximum possible cash incentives for fiscal year 2025 are as follows: Marc McConnell, $93,713 (35% of annual base retainer); and Michael Woods $31,668 (20% of annual base salary). The relevant objectives for fiscal year 2025 pertaining to the President, Chief Executive Officer and Chairman of the Board and Chief Financial Officer are related to EBITDA targets, defined strategic company objectives and continued debt retirement. Achievement of the objectives shall be determined in the Board’s discretion following the conclusion of fiscal year 2025.

 

Equity awards have historically been the third component of the Company’s compensation package for executive officers. Equity awards such as restricted stock are awarded to provide long-term incentives to align the objectives of executive officers with the interests of stockholders in maximizing long-term growth. Equity awards typically vest over three years.

 

The Company also has a 401(k) Savings Plan that covers substantially all full-time employees, including executive officers. Participating employees contribute to the 401(k) Savings Plan through salary reductions. The Company contributes a discretionary percentage of the 401(k) Savings Plan participants’ salary deferrals. The Company typically matches 50% of a participant’s contribution for every 1% that the participant contributes, up to 3% of the participant’s salary. Management of the 401(k) Savings Plan assets is currently vested with Transamerica. Vesting of participants’ company match is 20% per year of employment until 100% vested after six years.

 

Employment of Marc H. McConnell

 

Mr. McConnell was appointed to the role of President and Chief Executive Officer of the Company on October 4, 2024. He served as the Chairman of the Company’s board of directors throughout fiscal year 2024. During fiscal year 2024, Mr. McConnell received a cash retainer of $267,750 (paid in monthly installments) in connection with his service as Chairman of the Board. On February 7, 2024, he received 20,000 shares of restricted stock for which risks of forfeiture lapsed as to 6,666 shares on February 7, 2025 and will lapse as to 6,667 shares on each of February 7, 2026 and February 7, 2027. During fiscal year 2024, Mr. McConnell also received 5,000 shares of fully vested restricted stock in connection with his board service under the director compensation policy in place during fiscal year 2024, which provided for a stock award of 1,000 shares at the end of each fiscal quarter and an additional 1,000 share award upon a director’s re-election to the Company board of directors at last year’s annual meeting of stockholders.

 

 

Mr. McConnell began receiving a salary of $275,000 per year in lieu of his cash retainer on December 1, 2024 for his services as President, Chief Executive Officer and Chairman of the Board. He will continue to receive fully vested restricted stock in accordance with the director compensation policy and will be eligible for restricted stock awards at the compensation committees discretion.

 

On January 24, 2025, the Board granted Mr. McConnell 20,000 shares of restricted stock for which the risks of forfeiture lapse as to 6,666 shares on January 24, 2026, and as to 6,667 shares on each of January 24, 2027 and January 24, 2028. Mr. McConnell’s restricted stock awards are governed by the 2020 Equity Incentive Plan and the Company’s form of restricted stock award agreement.

 

Employment of Michael W. Woods

 

Mr. Woods’s employment as Chief Financial Officer is governed by an employment agreement entered into as of February 1, 2020. Mr. Woods has an annual base salary of $158,346. Mr. Woods is also eligible to receive incentive compensation, including cash bonuses and equity awards, in the exclusive discretion of the Board (or a committee authorized by the Board), and to participate in any and all other employee benefit plans that are generally available to the Company’s employees.

 

Mr. Woods’s employment agreement may be terminated at any time by either party. If the agreement is terminated by the Company without cause (as defined in the Agreement), the Company may be required to pay up to 8 weeks of compensation and benefits to Mr. Woods, in exchange for his release of any and all claims against the Company and his compliance with the non-competition and non-solicitation provisions of the agreement. The agreement also contains confidentiality and assignment of inventions provisions that survive the termination of the agreement for an indefinite period.

 

On January 24, 2025, the Board granted Mr. Woods 10,000 shares of restricted stock for which the risks of forfeiture lapse as to 3,334 shares on January 24, 2026, and as to 3,333 shares on each of January 24, 2027 and January 24, 2028. Mr. Wood’s restricted stock awards are governed by the 2020 Equity Incentive Plan and the Company’s form of restricted stock award agreement.

 

Prior Employment of David A. King

 

Prior to his termination of employment on October 1, 2024, Mr. King’s employment was governed by an employment agreement entered into effective March 30, 2020. Mr. King was being compensated at an annual base salary rate of $275,000, immediately prior to his termination of employment. On October 1, 2024, Mr. King and the Company entered into a separation agreement and general release in connection with his termination of employment. Under the separation agreement, Mr. King was entitled to severance pay equal to 12 weeks of his base salary at the rate in effect on his separation date, with such amount payable in substantially equal installments in accordance with the Company’s regular payroll schedule. The Company also agreed (subject to a timely COBRA election by Mr. King) to pay an amount equal to the monthly employer contribution that the Company would have made to provide health insurance to Mr. King if he had remained employed by the Company for the first three months of coverage following the separation date. The separation agreement further provided for general release and non-disparagement provisions running in favor of the Company, and acknowledged that the confidentiality, non-competition and assignment of invention provisions of his prior employment agreement would survive the termination of such agreement.

 

2024 Say on Pay Results

 

At our Annual Meeting held on April 23, 2024, our stockholders had the opportunity to cast a non-binding advisory vote on the compensation of our named executive officers and 95.3% of the shares present and entitled to vote on the proposal (excluding, for clarity, broker note-votes) approved our named executive officers’ compensation. The Board and the Compensation Committee welcomed this feedback and intend to continue their practice of linking Company performance with executive compensation decisions in order to maximize long-term stockholder value.

 

 

Executive Compensation Clawback Policy

 

The Board has adopted a Clawback Policy intended to comply with the clawback rules adopted by the SEC pursuant to Section 10D and Rule 10D-1 of the Exchange Act, and the related Nasdaq listing requirements (together, the “Clawback Rules”). The Clawback Policy requires the Company to recover reasonably promptly any erroneously awarded incentive-based compensation received by current and former executive officers (as defined in the Clawback Policy) of the Company in the event that the Company is required to prepare an accounting restatement, in accordance with the Clawback Rules. The recovery of such compensation applies regardless of whether an executive officer engaged in misconduct or otherwise caused or contributed to the requirement of an accounting restatement. Under the Clawback Policy, the Company may recoup from current or former executive officers erroneously awarded incentive-based compensation received within a look-back period of the three completed fiscal years preceding the date on which the Company is required to prepare an accounting restatement. A copy of the policy was filed as Exhibit 97.1 to our Annual Report on Form 10-K for the fiscal year ended November 30, 2024.

 

Policies and Practices Related to Stock Option Grants

 

The following discussion of the timing of option awards in relation to the disclosure of material nonpublic information is provided as required by Item 402(x) of SEC Regulation S-K. The Company does not have a written policy regarding the timing of option awards in relation to the disclosure of material nonpublic information. The Company has not issued stock options since 2015 and it is not currently a major part of its compensation strategy. The Board's schedule for determining when to grant options occurs annually at a compensation committee meeting typically in January. The Compensation Committee does not take material nonpublic information into account when determining the timing and terms of option awards. The Company has not timed the disclosure of material nonpublic information to affect the value of executive compensation.

 

Summary Compensation Table 

 

The following table sets forth all compensation paid or payable by the Company during the last two fiscal years to the Company’s named executive officers.

 

Name and Position	Fiscal Year	Salary ($)	Bonus ($) (1)	Stock Awards ($) (2)	All Other Compensation ($) (3) (4)	Total ($)
Marc McConnell (5)	2024	-	30,000	51,870	267,500	349,370
Chairman, President and Chief Executive Officer	2023	-	-	-	-	-
Michael Woods	2024	151,698	35,000	21,200	4,551	212,449
Chief Financial Officer	2023	134,363	12,750	17,990	4,031	169,134
David King	2024	219,933	-	42,400	63,462	342,004
Former President and Chief Executive Officer	2023	283,461	25,000	64,250	17,556	390,267

 

(1)	Represents discretionary bonuses awarded for respective fiscal year performance.
(2)	Represents the grant date fair value of restricted stock awarded during the fiscal years ended November 30, 2024 and November 30, 2023, in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation — Stock Compensation. Please refer to Note 13 of the financial statements included in our Form 10-K for fiscal year 2024 for a discussion of the assumptions made in the valuation of restricted stock awards. For Mr. McConnell, includes (i) 5,000 shares of fully vested restricted stock granted in 2024 under the Company’s director compensation policy in effect during fiscal year 2024, and (ii) a restricted stock award, subject to a three-year vesting schedule, of 20,000 shares awarded in connection with his role as Chairman of the Board during fiscal year 2024.
(3)	All other compensation includes personal use of company vehicle and Company 401(k) match.
(4)	Included in the “All Other Compensation” column for Mr. McConnell are aggregate payments of $267,500 under a cash retainer (paid in monthly installments) in connection with his board service as Chairman of the Board during the fiscal year 2024. Included in the “All Other Compensation” column for Mr. King for fiscal year 2024 are separation payments in the aggregate amount of $63,462 paid under a separation agreement and release entered into in connection with the termination of his employment on October 1, 2024.
(5)	Mr. McConnell was not a named executive officer during fiscal year 2023, and, accordingly, no compensation information is included for him with respect to fiscal year 2023. Compensation information for Mr. McConnell received in fiscal year 2023 with respect to his service as a director of the Company was previously disclosed in the Company’s definitive proxy statement filed with the SEC on March 15, 2024.

 

 

 

 

Outstanding Equity Awards at 2024 Fiscal Year-End

 

The following table sets forth the number of shares underlying outstanding equity awards as of November 30, 2024 and additional information relating to such awards:

 

	OPTION AWARDS					STOCK AWARDS
Name	Number of securities underlying unexercised options (#) exercisable	Number of securities underlying unexercised options (#) unexercisable	Option Exercise Price ($)	Option Expiration Date		Number of Shares or Units of Stock that Have Not Vested (#)	Market Value of Shares or Units that Have Not Vested ($) (1)
David King	-	-	-	-		-	-
Marc McConnell	2,000	0	4.70	04/22/2025		-	-
	-	-	-	-		8,333 (2)	14,166
	-	-	-	-		16,666 (3)	28,332
	-	-	-	-		20,000 (4)	34,000
Michael Woods	-	-	-	-		2,333 (5)	3,966
	-	-	-	-		4,666 (6)	7,932
	-	-	-	-		10,000 (7)	17,000

 

(1)	Market value of shares of stock that have not vested computed based on closing market price of $1.70 on November 29, 2024 (last trading day prior to 2024 fiscal year end).

(2)	Risks of forfeiture for these shares of restricted stock lapsed as to 8,333 shares on January 27, 2025.
(3)	Risks of forfeiture for these shares of restricted stock lapsed as to 8,333 shares on January 26, 2025 and will lapse as to 8,333 shares on January 26, 2026.
(4)	Risks of forfeiture for these shares of restricted stock lapsed as to 6,666 shares on February 7, 2025 and will lapse as to 6,667 shares on each of February 7, 2026 and February 7, 2027.
(5)	Risks of forfeiture for these shares of restricted stock lapsed as to 2,333 shares on January 27, 2025.
(6)	Risks of forfeiture for these shares of restricted stock lapsed as to 2,333 shares on January 26, 2025 and will lapse as to 2,333 shares on January 26, 2026.
(7)	Risks of forfeiture for these shares of restricted stock lapsed as to 3,334 shares on February 7, 2025 and will lapse as to 3,333 shares on each of February 7, 2026 and February 7, 2027.

 

 

 

 

DIRECTOR COMPENSATION

 

The Company maintains a written director compensation policy. During fiscal year 2024, each director, other than the Chairman of the Board, was entitled to receive a $24,000 cash retainer for service as a director during the fiscal year, with no committee or attendance fees pursuant to this policy. The Chairmen of the Audit Committee and the Compensation Committee were each entitled to receive an additional cash retainer of $4,000 per fiscal year.

 

Director retainers are paid quarterly in installments and are prorated to reflect a director who serves for less than a full fiscal year. Directors may, in accordance with certain timing parameters determined by the Board, elect to receive fully vested restricted common stock in lieu of the aforementioned cash retainers. Any such stock shall be issued under the Company’s 2020 Equity Incentive Plan or, if determined by the Board, an applicable successor plan approved by the Company’s stockholders. In addition, each director is reimbursed for out-of-pocket expenses to attend all Board meetings and perform other services as a Board member. Director compensation is reviewed annually, and adjustments may be adopted by the Board.

 

The Company’s director compensation policy in place during fiscal year 2024 also provided for annual grants of 1,000 shares of fully vested restricted shares of Company common stock on the date of each annual meeting and for quarterly grants of 1,000 shares of fully vested restricted shares of Company common stock on the last day of each fiscal quarter. In fiscal year 2024, the annual director restricted shares grant was made on April 23, 2024 to the directors elected to the Board at the 2024 Annual Meeting of Stockholders. For the 2025 fiscal year and upon recommendation of the Company’s Compensation Committee, the Board increased the annual award of fully-vested restricted stock that directors would receive upon reelection to the Board at the annual stockholders meeting from 1,000 shares to 3,500 shares.

 

Director Compensation Table for Fiscal Year 2024

 

The following table sets forth the compensation received by our directors for fiscal year 2024. Director compensation for Mr. McConnell, who is also a named executive officer, is omitted from the table below, as such compensation for fiscal year 2024 is fully reflected in the Summary Compensation Table above for our named executive officers.

 

Director Name	Fees Earned or Paid in Cash ($)	Stock Awards ($) (1)	Option Awards ($) (2)	Total ($)
Thomas E. Buffamante	28,000	9,470	-	37,470
Randall C. Ramsey	24,000	9,470	-	33,470
Matthew Westendorf	24,000	9,470	-	33,470
David A. White	28,000	9,470	-	37,470

 

(1)	Represents the grant date fair value of equity-based compensation for 5,000 shares of fully-vested restricted stock granted pursuant to the Company’s director compensation policy in effect during fiscal year 2024 at the grant date fair value of: $1.97 per share for grants of 1,000 shares made February 29, 2024; $1.99 per share for grants of 1,000 shares made April 23, 2024; $1.74 per share for grants of 1,000 shares made May 31, 2024, $2.07 per share for grants of 1,000 shares made August 31, 2024, and $1.70 per share for grants of 1,000 shares made November 30, 2024, in accordance with Financial Accounting Standards Board’s Accounting Standards Codification (ASC) Topic 718, Compensation – Stock Compensation. Please refer to Note 13 of the financial statements included in our Form 10-K for fiscal year 2024 for a discussion of the assumptions made in the valuation of restricted stock awards.
(2)	No option awards were granted to directors in fiscal year 2024. At the end of fiscal year 2024 the aggregate number of shares underlying option awards outstanding for each director identified in the above table was as follows: Thomas E. Buffamante – 2,000. All outstanding options held by Mr. Buffamante were exercisable as of the end of fiscal year 2024.

 

 

EQUITY COMPENSATION PLAN INFORMATION 

 

The following table provides information concerning the Art’s-Way Manufacturing Co., Inc. 2011 Equity Incentive Plan and the Art’s-Way Manufacturing Co., Inc. 2020 Equity Incentive Plan as of November 30, 2024.

 

	Number of securities to be issued upon exercise of outstanding options	Weighted average exercise price of outstanding options	Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
	(a)	(b)	(c)
Equity compensation plans approved by security holders	4,000	$4.70	204,679
Equity compensation plans not approved by security holders	-	N/A	-
Totals	4,000	$4.70	204,679

 

 

PAY VERSUS PERFORMANCE

 

As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, the Company is providing the following information about the relationship between executive compensation actually paid and certain financial performance of the Company.

 

Pay Versus Performance Table

 

Fiscal Year Ended November 30:		Summary compensation table total for David King (1) ($)		Summary compensation total table for Marc McConnell (2) ($)		Compensation actually paid to David King (3) ($)		Compensation actually paid to Marc McConnell (4) ($)		Average summary compensation table total for non-PEO named executive officers (5) ($)		Average compensation actually paid to non-PEO named executive officers (6) ($)		Value of initial fixed $100 investment based on: Total shareholder return (7) ($)		Net Income (8) ($)
2024		342,004		349,370		248,573		328,367		212,449		205,149		82.52		307,375
2023		390,267		-		388,501		-		169,134		169,697		57.91		266,969
2022		424,793		-		387,643		-		162,729		142,654		54.80		97,797

 

(1)	Mr. King served as the Company’s principal executive officer, or PEO, during the 2022 and 2023 fiscal years and during the 2024 fiscal year until his termination of employment on October 1, 2024.
(2)	Mr. McConnell served as the Company’s PEO during fiscal year 2024 for the period between October 4, 2024 – November 30, 2024. He did not serve as the Company’s PEO during any portion of the 2023 or 2022 fiscal years.

 

23

---

 

 

(3)

The dollar amounts reported in this column for Mr. King represent the amounts of “compensation actually paid” to Mr. King, as computed in accordance with Item 402(v) of Regulation S-K, during the 2022, 2023, and 2024 fiscal years. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr. King during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Mr. King’s total compensation for each year to determine the compensation actually paid:

 

Fiscal Year Ended November 30:		Reported Summary Compensation Table Total for Mr. King ($)		Reported Value of Equity Awards(a) ($)		Equity Awards Adjustments(b) ($)		Compensation Actually Paid to Mr. King ($)
2024		342,004		(42,400)		(51,031)		248,573
2023		390,267		(64,250)		62,484		388,501
2022		424,793		(80,500)		43,350		387,643

 

(a)

The grant date fair value of equity awards represents the total of the amounts reported in the “Awards” column in the Summary Compensation Table for the applicable year.

 

(b)

The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) addition of the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) addition of the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, addition of the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, addition of the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) addition of the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:

 

Fiscal Year Ended November 30:		Year End Fair Value of Equity Awards ($)		Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards ($)		Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($)		Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year ($)		Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year ($)		Fair Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation ($)		Total Equity Award Adjustments ($)
2024		-		-		-		467		(51,498)		-		(51,031)
2023		51,500		2,567		-		8,417		-		-		62,484
2022		48,750		(52,999)		-		47,600		-		-		43,350

 

24

---

 

 

(4)

The dollar amount reported in this column for Mr. McConnell represent the amount of “compensation actually paid” to Mr. McConnell, as computed in accordance with Item 402(v) of Regulation S-K, during the 2024 fiscal year. The dollar amount does not reflect the actual amount of compensation earned by or paid to Mr. McConnell during the year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Mr. McConnell’s total compensation for the 2024 fiscal year to determine the compensation actually paid:

 

Fiscal Year Ended November 30:		Reported Summary Compensation Table Total for Mr. McConnell ($)		Reported Value of Equity Awards(a) ($)		Equity Awards Adjustments(b) ($)		Compensation Actually Paid to Mr. McConnell ($)
2024		349,370		(51,870)		30,867		328,367

 

(a)

The grant date fair value of equity awards represents the total of the amounts reported in the “Awards” column in the Summary Compensation Table for the year.

 

(b)

The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) addition of the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) addition of the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, addition of the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, addition of the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) addition of the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:

 

Fiscal Year Ended November 30:		Year End Fair Value of Equity Awards ($)		Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards ($)		Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($)		Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year ($)		Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year ($)		Fair Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation ($)		Total Equity Award Adjustments ($)
2024		34,000		(3,600)		9,470		467		-		-		30,867

 

(5)

The dollar amounts reported in this column represent the amounts reported for our named executive officers, or NEOs (excluding each person serving as our PEO in the applicable fiscal year) in the “Total” column of the Summary Compensation Table in each applicable year. The only NEO (excluding our PEO(s)) included for purposes of calculating the amounts in each applicable year was Michael Woods, our Chief Financial Officer, who was the only NEO (other than our PEO(s)) during each fiscal year.

 

25

---

 

 

(6)

The dollar amounts reported in this column represent the amounts of “compensation actually paid” to the NEO (excluding each person serving as our PEO in the applicable fiscal year), as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEO (excluding our PEO(s)) during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the NEO (excluding our PEO(s)) for each year to determine the compensation actually paid, using the same methodology described above in Note (3):

 

Fiscal Year Ended November 30:		Reported Summary Compensation Table Total for Non-PEO NEO ($)		Reported Value of Equity Awards(a) ($)		Equity Awards Adjustments(b) ($)		Compensation Actually Paid to Non-PEO NEO ($)
2024		212,449		(21,200)		13,900		205,149
2023		169,134		(17,990)		18,553		169,697
2022		162,729		(22,540)		2,465		142,654

 

(a)The grant date fair value of equity awards represents the total of the amounts reported in the “Awards” column in the Summary Compensation Table for the applicable year.

 

26

---

 

 

(b)The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) addition of the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) addition of the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, addition of the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, addition of the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) addition of the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:

 

Fiscal Year Ended November 30:		Year End Fair Value of Equity Awards ($)		Year Over Year Change in Fair Value of Outstanding and  Unvested  Equity Awards ($)		Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($)		Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year ($)		Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year ($)		Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation ($)		Total Equity Award Adjustments ($)
2024		17,000		(3,240)		-		140		-		-		13,900
2023		14,420		770		-		3,363		-		-		18,553
2022		13,650		(10,068)		-		(1,117)		-		-		2,465

 

(7)

Cumulative total shareholder return (Cumulative TSR) is calculated by dividing (i) the sum of (A) the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and (B) the difference between the Company’s share price at the end and the beginning of the measurement period, by (ii) the Company’s share price at the beginning of the measurement period.

 

(8)	The dollar amounts reported represent the amount of net income reflected in the Company’s audited financial statements for the applicable year.

 

 

27

---

 

 

 

Analysis of the Information Presented in the Pay versus Performance Table

 

In accordance with Item 402(v) of Regulation S-K, we are providing the following descriptions of the relationships between information presented in the Pay Versus Performance table above.

 

Compensation Actually Paid and Cumulative TSR

 

The following graphs set forth the relationship between Compensation Actually Paid to our PEO (and with respect to fiscal year 2024, both our PEOs during that year), the Compensation Actually Paid to our Non-PEO NEO, and the Company’s cumulative TSR over the three most recently completed fiscal years.

 

 

 

 

 

28

---

 

 

Compensation Actually Paid and Net Income

 

The following graph sets forth the relationship between Compensation Actually Paid to our PEO (and with respect to fiscal year 2024, both our PEOs during that year), the Compensation Actually Paid to our Non-PEO NEO, and the Company’s net income over the three most recently completed fiscal years.

 

 

DELINQUENT SECTION 16(a) REPORTS

 

Section 16(a) of the Exchange Act requires our executive officers and directors, and persons who own more than 10% of our common stock, to file reports regarding ownership of, and transactions in, our securities with the Securities and Exchange Commission and to provide us with copies of those filings. To the Company’s knowledge, based solely on a review of the copies of such reports furnished to the Company and written representations that no other reports were required, during the fiscal year ended November 30, 2024, all such filing requirements applicable to the Company’s directors, executive officers and greater than 10% beneficial owners were complied with, except that (i) Messrs. Buffamante, McConnell, Ramsey, Westendorf, and White each untimely filed a Form 4 reporting one transaction, which was a quarterly grant of stock to them as Board members pursuant to the director compensation policy as described above, and (ii) Messrs. King and Woods each untimely filed a Form 4 reporting one transaction, which was the forfeiture of shares of Company common stock to pay withholding taxes in connection with the vesting of restricted stock.

 

 

CERTAIN TRANSACTIONS AND BUSINESS RELATIONSHIPS

 

Other than as described below, since the beginning of our fiscal year 2023, there have been no transactions or series of transactions to which we were a participant or will be a participant in which:

 

	•	the amounts involved exceeded the lesser of $120,000 or one percent of the average of our total assets at year-end for our last two completed fiscal years; and
	•	a director, executive officer, beneficial owner of more than 5% of any class of our voting securities or any member of their immediate family had or will have a direct or indirect material interest.

 

McConnell Legacy Investments LLC is our largest shareholder and partially owned by a trust under the terms of the Estate of our former Vice Chairman of our Board, J. Ward McConnell. The trust is providing a guarantee of approximately 38% of the balance of our $2,600,000 term loan from Bank Midwest, as required by the United States Department of Agriculture in connection with its guarantee of the same loan. In exchange, the trust receives a fee of 2% of the personally guaranteed amount. For fiscal years 2023 and 2024, the fee paid to the guarantor was $16,102 and $15,193, respectively.

 

OTHER INFORMATION

 

Management knows of no other matters that may be brought before the 2025 Annual Meeting. If any other matters are presented at the meeting on which a vote may properly be taken, the persons named as proxy holders on the enclosed proxy card will vote thereon in accordance with their discretion and best judgment.

 

ANNUAL REPORT AND FINANCIAL STATEMENTS

 

The Company’s Form 10-K, including the Company’s financial statements and the notes thereto for the fiscal year ended November 30, 2024, accompanies the delivery of this Proxy Statement.

 

We will provide a copy of exhibits to the Form 10-K upon written request and payment of specified fees. The written request for such Form 10-K and/or exhibits should be directed to Marc McConnell, President, Chief Executive Officer and Chairman of Art’s-Way Manufacturing Co., Inc., 5556 Highway 9, Armstrong, Iowa, 50514-0288. Such request must set forth a good faith representation that the requesting party was a holder of record or a beneficial owner of common stock of the Company on March 7, 2025. The Form 10-K complete with exhibits and the Proxy Statement are also available at no cost through the EDGAR database available from the SEC’s website (www.sec.gov) and on our website at http://www.artsway-mfg.com/investor-relations/.

 

 

 

 

v3.25.0.1

Cover	12 Months Ended
	Dec. 31, 2024
Document Information [Line Items]
Document Type	DEF 14A
Amendment Flag	false
Entity Information [Line Items]
Entity Registrant Name	ART’S-WAY MANUFACTURING CO., INC.
Entity Central Index Key	0000007623

v3.25.0.1

Pay vs Performance Disclosure - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Pay vs Performance Disclosure, Table	PAY VERSUS PERFORMANCE   As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, the Company is providing the following information about the relationship between executive compensation actually paid and certain financial performance of the Company.   Pay Versus Performance Table   Fiscal Year Ended November 30:   Summary compensation table total for David King (1) ($)   Summary compensation total table for Marc McConnell (2) ($)   Compensation actually paid to David King (3) ($)   Compensation actually paid to Marc McConnell (4) ($)   Average summary compensation table total for non-PEO named executive officers (5) ($)   Average compensation actually paid to non-PEO named executive officers (6) ($)   Value of initial fixed $100 investment based on: Total shareholder return (7) ($)   Net Income (8) ($) 2024   342,004   349,370   248,573   328,367   212,449   205,149   82.52   307,375 2023   390,267   -   388,501   -   169,134   169,697   57.91   266,969 2022   424,793   -   387,643   -   162,729   142,654   54.80   97,797   (1) Mr. King served as the Company’s principal executive officer, or PEO, during the 2022 and 2023 fiscal years and during the 2024 fiscal year until his termination of employment on October 1, 2024. (2) Mr. McConnell served as the Company’s PEO during fiscal year 2024 for the period between October 4, 2024 – November 30, 2024. He did not serve as the Company’s PEO during any portion of the 2023 or 2022 fiscal years.     (3) The dollar amounts reported in this column for Mr. King represent the amounts of “compensation actually paid” to Mr. King, as computed in accordance with Item 402(v) of Regulation S-K, during the 2022, 2023, and 2024 fiscal years. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr. King during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Mr. King’s total compensation for each year to determine the compensation actually paid:
PEO Total Compensation Amount	$ 349,370	$ 0	$ 0
PEO Actually Paid Compensation Amount	$ 328,367	0	0
Adjustment To PEO Compensation, Footnote	Fiscal Year Ended November 30:   Reported Summary Compensation Table Total for Mr. King ($)   Reported Value of Equity Awards(a) ($)   Equity Awards Adjustments(b) ($)   Compensation Actually Paid to Mr. King ($) 2024   342,004   (42,400)   (51,031)   248,573 2023   390,267   (64,250)   62,484   388,501 2022   424,793   (80,500)   43,350   387,643     (a) The grant date fair value of equity awards represents the total of the amounts reported in the “Awards” column in the Summary Compensation Table for the applicable year.     (b) The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) addition of the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) addition of the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, addition of the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, addition of the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) addition of the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:   Fiscal Year Ended November 30:   Year End Fair Value of Equity Awards ($)   Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards ($)   Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($)   Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year ($)   Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year ($)   Fair Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation ($)   Total Equity Award Adjustments ($) 2024   -   -   -   467   (51,498)   -   (51,031) 2023   51,500   2,567   -   8,417   -   -   62,484 2022   48,750   (52,999)   -   47,600   -   -   43,350     (4) The dollar amount reported in this column for Mr. McConnell represent the amount of “compensation actually paid” to Mr. McConnell, as computed in accordance with Item 402(v) of Regulation S-K, during the 2024 fiscal year. The dollar amount does not reflect the actual amount of compensation earned by or paid to Mr. McConnell during the year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Mr. McConnell’s total compensation for the 2024 fiscal year to determine the compensation actually paid:     Fiscal Year Ended November 30:   Reported Summary Compensation Table Total for Mr. McConnell ($)   Reported Value of Equity Awards(a) ($)   Equity Awards Adjustments(b) ($)   Compensation Actually Paid to Mr. McConnell ($) 2024   349,370   (51,870)   30,867   328,367     (a) The grant date fair value of equity awards represents the total of the amounts reported in the “Awards” column in the Summary Compensation Table for the year.     (b) The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) addition of the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) addition of the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, addition of the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, addition of the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) addition of the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:   Fiscal Year Ended November 30:   Year End Fair Value of Equity Awards ($)   Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards ($)   Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($)   Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year ($)   Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year ($)   Fair Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation ($)   Total Equity Award Adjustments ($) 2024   34,000   (3,600)   9,470   467   -   -   30,867   (5) The dollar amounts reported in this column represent the amounts reported for our named executive officers, or NEOs (excluding each person serving as our PEO in the applicable fiscal year) in the “Total” column of the Summary Compensation Table in each applicable year. The only NEO (excluding our PEO(s)) included for purposes of calculating the amounts in each applicable year was Michael Woods, our Chief Financial Officer, who was the only NEO (other than our PEO(s)) during each fiscal year.     (6) The dollar amounts reported in this column represent the amounts of “compensation actually paid” to the NEO (excluding each person serving as our PEO in the applicable fiscal year), as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEO (excluding our PEO(s)) during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the NEO (excluding our PEO(s)) for each year to determine the compensation actually paid, using the same methodology described above in Note (3):
Non-PEO NEO Average Total Compensation Amount	$ 212,449	169,134	162,729
Non-PEO NEO Average Compensation Actually Paid Amount	$ 205,149	169,697	142,654
Adjustment to Non-PEO NEO Compensation Footnote	Fiscal Year Ended November 30:   Reported Summary Compensation Table Total for Non-PEO NEO ($)   Reported Value of Equity Awards(a) ($)   Equity Awards Adjustments(b) ($)   Compensation Actually Paid to Non-PEO NEO ($) 2024   212,449   (21,200)   13,900   205,149 2023   169,134   (17,990)   18,553   169,697 2022   162,729   (22,540)   2,465   142,654       (a)The grant date fair value of equity awards represents the total of the amounts reported in the “Awards” column in the Summary Compensation Table for the applicable year.         (b)The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) addition of the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) addition of the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, addition of the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, addition of the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) addition of the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:   Fiscal Year Ended November 30:   Year End Fair Value of Equity Awards ($)   Year Over Year Change in Fair Value of Outstanding and  Unvested  Equity Awards ($)   Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($)   Year over Year Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year ($)   Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year ($)   Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation ($)   Total Equity Award Adjustments ($) 2024   17,000   (3,240)   -   140   -   -   13,900 2023   14,420   770   -   3,363   -   -   18,553 2022   13,650   (10,068)   -   (1,117)   -   -   2,465   (7) Cumulative total shareholder return (Cumulative TSR) is calculated by dividing (i) the sum of (A) the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and (B) the difference between the Company’s share price at the end and the beginning of the measurement period, by (ii) the Company’s share price at the beginning of the measurement period.   (8) The dollar amounts reported represent the amount of net income reflected in the Company’s audited financial statements for the applicable year.
Compensation Actually Paid vs. Total Shareholder Return	Analysis of the Information Presented in the Pay versus Performance Table   In accordance with Item 402(v) of Regulation S-K, we are providing the following descriptions of the relationships between information presented in the Pay Versus Performance table above.   Compensation Actually Paid and Cumulative TSR   The following graphs set forth the relationship between Compensation Actually Paid to our PEO (and with respect to fiscal year 2024, both our PEOs during that year), the Compensation Actually Paid to our Non-PEO NEO, and the Company’s cumulative TSR over the three most recently completed fiscal years.
Compensation Actually Paid vs. Net Income	Compensation Actually Paid and Net Income   The following graph sets forth the relationship between Compensation Actually Paid to our PEO (and with respect to fiscal year 2024, both our PEOs during that year), the Compensation Actually Paid to our Non-PEO NEO, and the Company’s net income over the three most recently completed fiscal years.
Total Shareholder Return Amount	$ 82.52	57.91	54.8
Net Income (Loss)	307,375	266,969	97,797
PEO Reported Value Of Equity Awards [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	(51,870)
PEO Equity Awards Adjustments [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	30,867
PEO Year End Fair Value Of Equity Awards [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	34,000
PEO Year Over Year Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	(3,600)
PEO Fair Value As Of Vesting Date Of Equity Awards Granted And Vested In The Year [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	9,470
PEO Year Over Year Change In Fair Value Of Equity Awards Granted In Prior Years That Vested In The Year [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	467
PEO Fair Value At The End Of The Prior Year Of Equity Awards That Failed To Meet Vesting Conditions In The Year [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	0
PEO Fair Value Of Dividends Or Other Earnings Paid On Stock Or Option Awards Not Otherwise Reflected In Fair Value Or Total Compensation [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	0
PEO Total Equity Award Adjustments [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	30,867
NEO Reported Value Of Equity Awards [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	(21,200)	(17,990)	(22,540)
NEO Equity Awards Adjustments [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	13,900	18,553	2,465
NEO Year End Fair Value Of Equity Awards [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	17,000	14,420	13,650
NEO Year Over Year Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	(3,240)	770	(10,068)
NEO Fair Value As Of Vesting Date Of Equity Awards Granted And Vested In The Year [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	0	0	0
NEO Year Over Year Change In Fair Value Of Equity Awards Granted In Prior Years That Vested In The Year [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	140	3,363	(1,117)
NEO Fair Value At The End Of The Prior Year Of Equity Awards That Failed To Meet Vesting Conditions In The Year [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	0	0	0
NEO Value Of Dividends Or Other Earnings Paid On Stock Or Option Awards Not Otherwise Reflected In Fair Value Or Total Compensation [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	0	0	0
NEO Total Equity Award Adjustments [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	13,900	18,553	2,465
Former PEO [Member]
Pay vs Performance Disclosure
PEO Total Compensation Amount	342,004	390,267	424,793
PEO Actually Paid Compensation Amount	248,573	388,501	387,643
Former PEO [Member] | PEO Reported Value Of Equity Awards [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	(42,400)	(64,250)	(80,500)
Former PEO [Member] | PEO Equity Awards Adjustments [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	(51,031)	62,484	43,350
Former PEO [Member] | PEO Year End Fair Value Of Equity Awards [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	0	51,500	48,750
Former PEO [Member] | PEO Year Over Year Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	0	2,567	(52,999)
Former PEO [Member] | PEO Fair Value As Of Vesting Date Of Equity Awards Granted And Vested In The Year [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	0	0	0
Former PEO [Member] | PEO Year Over Year Change In Fair Value Of Equity Awards Granted In Prior Years That Vested In The Year [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	467	8,417	47,600
Former PEO [Member] | PEO Fair Value At The End Of The Prior Year Of Equity Awards That Failed To Meet Vesting Conditions In The Year [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	(51,498)	0	0
Former PEO [Member] | PEO Fair Value Of Dividends Or Other Earnings Paid On Stock Or Option Awards Not Otherwise Reflected In Fair Value Or Total Compensation [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	0	0	0
Former PEO [Member] | PEO Total Equity Award Adjustments [Member]
Pay vs Performance Disclosure
Adjustment to Compensation, Amount	$ (51,031)	$ 62,484	$ 43,350

---